MRD Monitoring in Acute Lymphoblastic Leukemia
0 Tampilan
administrator
06/15/23
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Menampilkan lebih banyak
Komentar Facebook
Tidak ada komentar yang ditemukan